
KYNTRA BIO, INC.
KYNTRA BIO, INC. (KYNB)
WebsitePrice
Market cap
Next catalystPhase 3 initiation goal in Q1 2027, subject to a strategic partnership or external capital raiseroxadustat — planned pivotal Phase 3 LR-MDS trial · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
HFB1011
CCR8
PreINDP1P2P3FilingApproved
Partner / License out
Approved / commercial
Approved
PreINDP1P2P3FilingApproved
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved